Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada; email:
Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Annu Rev Biochem. 2022 Jun 21;91:61-87. doi: 10.1146/annurev-biochem-032620-105344. Epub 2022 Apr 4.
Small molecule chemical probes are valuable tools for interrogating protein biological functions and relevance as a therapeutic target. Rigorous validation of chemical probe parameters such as cellular potency and selectivity is critical to unequivocally linking biological and phenotypic data resulting from treatment with a chemical probe to the function of a specific target protein. A variety of modern technologies are available to evaluate cellular potency and selectivity, target engagement, and functional response biomarkers of chemical probe compounds. Here, we review these technologies and the rationales behind using them for the characterization and validation of chemical probes. In addition, large-scale phenotypic characterization of chemical probes through chemical genetic screening is increasingly leading to a wealth of information on the cellular pharmacology and disease involvement of potential therapeutic targets. Extensive compound validation approaches and integration of phenotypic information will lay foundations for further use of chemical probes in biological discovery.
小分子化学探针是研究蛋白质生物学功能和作为治疗靶点相关性的有价值的工具。严格验证化学探针参数,如细胞效力和选择性,对于将化学探针治疗产生的生物学和表型数据与特定靶标蛋白的功能明确联系起来至关重要。现在有多种现代技术可用于评估细胞效力和选择性、靶标结合以及化学探针化合物的功能反应生物标志物。在这里,我们回顾了这些技术以及使用这些技术对化学探针进行表征和验证的基本原理。此外,通过化学遗传筛选对化学探针进行大规模表型特征分析,越来越多地为潜在治疗靶标的细胞药理学和疾病相关性提供了丰富的信息。广泛的化合物验证方法和表型信息的整合将为化学探针在生物学发现中的进一步应用奠定基础。